StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma statistics

40 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
-47.7%
10.8%
Shares Change (QoQ)
0.00%
0.50%
Float
7.15B
49M
Shares Held by Insiders
0.17%
11.7%

MarginsIndustry

Gross Margin
64.8%
53.1%
Operating Margin
-1017.8%
-38.7%
Pretax Margin
-3370.6%
-11.6%
Profit Margin
-3370.6%
-31.6%
EBITDA Margin
-1017.8%
-27.7%

Returns on capitalIndustry

Return on Assets (ROA)
-731.5%
-40.6%

Financial positionIndustry

Current Ratio
0.02
3.30
Quick Ratio
0.00
2.39
Interest Coverage
-68.24
-6.35

GrowthIndustry

Revenue Growth (YoY)
-49.0%
6.82%
Revenue Growth (3Y CAGR)
20.9%
2.25%
Revenue Growth (5Y CAGR)
37.8%
6.41%

EfficiencyIndustry

Asset Turnover
0.22
0.40
Inventory Turnover
7.90
2.73
Revenue Per Employee
$22.97K
$429.29K
Profits Per Employee
-$774.36K
-$689.41K
Employee Count
7
74

Income statement (TTM)Industry

Revenue
$160.82K
$66.37M
Gross Profit
$104.27K
$120.78M
Operating Income
-$1.64M
-$21.37M
Pretax Income
-$5.42M
-$12.95M
Net Income
-$5.42M
-$22.35M
EBITDA
-$1.64M
-$17.21M
EPS (Diluted)
$0.00
-$0.76

Balance sheetIndustry

Total Debt
$12.57M
$116.91M
Net Cash (Debt)
-$12.56M
$17.76M
Net Cash Per Share
-$0.00
$0.80
Equity (Book Value)
-$21.21M
$53.89M
Book Value Per Share
-$0.00
$1.50
Tangible Book Value
-$21.21M
$27.13M
Working Capital
-$21.23M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$1.05M
-$12.38M

Taxes and interestIndustry

Interest Expense
$23.99K
$2.90M

Scores and fair valueIndustry

Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodNPHCS&P 500DifferenceNPHC per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months-66.7%+3.4%−70.0 pts
Year to date0.0%+13.3%−13.3 pts
1 year0.0%+16.6%−16.6 pts
3 years0.0%+86.4%−86.4 pts0.0%+23.1%
5 years-96.4%+81.9%−178.3 pts-48.6%+12.7%
10 years-99.2%+318.9%−418.0 pts-38.0%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Jun 30, 2023.

0M NPHC shares were sold short on Jun 30, 2023, down 1.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Jun 30, 20234,924-1.0%616,3421.0
Jun 15, 20234,9740.0%1,073,2851.0
May 31, 20234,9740.0%483,1111.0
May 15, 20234,974-0.5%271,5151.0
Apr 28, 20235,000-20.0%199,3831.0
Apr 14, 20236,2500.0%763,3481.0
Mar 31, 20236,2500.0%2,6382.4
Mar 15, 20236,250–103,1071.0
Nov 30, 2021240.0%3,074,0411.0
Nov 15, 2021240.0%3,649,4841.0
Oct 29, 2021240.0%1,089,8961.0
Oct 15, 2021240.0%3,561,0181.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?